VSAR Shares Outstanding History
Below is a table of the VSAR shares outstanding history going back to 3/20/2014:

Date VSAR Shares Outstanding
3/20/201421.86M
4/30/201424.19M
7/31/201424.19M
10/31/201424.19M
2/28/201529.26M
4/30/201529.27M
7/31/201529.35M
10/31/201529.36M
2/29/201629.42M
4/29/201629.43M
7/29/201629.54M
11/2/201634.80M
2/28/201735.05M
4/30/201735.21M
7/31/201735.58M
10/31/201735.81M
2/28/201836.06M
4/9/201836.07M
4/30/201836.08M
7/31/201836.24M

Also see: VSAR Market Cap History
VSAR YTD Return
VSAR Historical Shares Outstanding:
+12.28% CAGR
VSAR Historical Shares Outstanding: +12.28% CAGR

Mouse over chart for data details
3/20/2014 ...7/31/2018
Aravive is an endocrine-focused biopharmaceutical company that engaged in developing a long-acting form of recombinant human growth hormone (rhGH), somavaratan (VRS-317), for growth hormone deficiency (GHD), an orphan disease that affects pediatric and adult patients. Somavaratan is a fusion protein consisting of rhGH and a proprietary half-life extension technology known as XTEN™. Somavaratan includes a long N-terminal XTEN sequence, XTEN1, which is added to rhGH as a fusion protein, increasing the hydrodynamic size of the rhGH and thereby reducing glomerular filtration. A C-terminal XTEN sequence, XTEN2, is also added to reduce receptor mediated clearance by decreasing receptor binding. We show 20 historical shares outstanding datapoints in our coverage of VSAR's shares outstanding history.

Understanding the changing numbers of VSAR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VSAR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VSAR by allowing them to research VSAR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VSAR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Versartis (VSAR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VSTM Shares Outstanding History
VTGN Shares Outstanding History
VTL Shares Outstanding History
VTRS Shares Outstanding History
VTVT Shares Outstanding History
VVOS Shares Outstanding History
VVUS Shares Outstanding History
VXRT Shares Outstanding History
VYGR Shares Outstanding History
VYNE Shares Outstanding History
More Healthcare companies »

 

VSAR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.